Schedule 13D ownership disclosure

Tenaya Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 87990A106

Event date: 2026-02-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • The Column Group III, LPReported CIK 0001668159

    Shares: 0 · Class: 0%

  • The Column Group III-A, LPReported CIK 0001668085

    Shares: 0 · Class: 0%

  • The Column Group III GP, LPReported CIK 0001790965

    Shares: 0 · Class: 0%

  • The Column Group Opportunity III, LPReported CIK 0001931825

    Shares: 49,313,559 · Class: 23.1%

  • The Column Group Opportunity III GP, LPReported CIK 0001932874

    Shares: 49,313,559 · Class: 23.1%

  • TCG Opportunity III GP, LLCReported CIK 0001932445

    Shares: 49,313,559 · Class: 23.1%

  • Tim KutzkeyReported CIK 0001614186

    Shares: 49,313,559 · Class: 23.1%

  • Peter SvennilsonReported CIK 0001606074

    Shares: 49,313,559 · Class: 23.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-076892
Form type
SCHEDULE 13D/A
Filer
COLUMN GROUP III, LP
CIK
CIK 1668159
Filed
Feb 26, 2026
Reporting period
Feb 25, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub